Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma

Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma

Mucin 1 is a transmembrane glycoprotein which overexpresses cancer-specific epitopes (MUC1-CE) on pancreatic ductal adenocarcinoma (PDAC) cells. As PDAC is a low survival and highly aggressive malignancy, developing radioimmunoconjugates capable of targeting MUC1-CE could lead to improvements in PDA...

Full description

Bibliographic Details
Main Authors: Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, William Tieu, Tara L. Pukala, Alexander H. Staudacher, Eva Bezak
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cells
Subjects:
pancreatic cancer
radioimmunoconjugates
mucin 1
C595
Online Access:https://www.mdpi.com/2073-4409/11/19/2983

Internet

https://www.mdpi.com/2073-4409/11/19/2983

Similar Items